DOI: 10.1055/s-00000077

Seminars in Thrombosis and Hemostasis

LinksClose Window

References

Finks SW, Rogers KC.
Idarucizumab (Praxbind): the first reversal agent for a direct oral anticoagulant.

Am J Med 2017;
130 (05) e195-e197

Download Bibliographical Data

Access:
Access:
Access:

We do not assume any responsibility for the contents of the web pages of other providers.